Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. (Q53851964)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2005

Language	Label	Description	Also known as
English	Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.	scientific article published in September 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

3

object named as

Shibo Jiang

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

author name string

Qian Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Liying Ma

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Hong Lu

4

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Shuwen Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Yuxian He

6

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Nathan Strick

7

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Nouri Neamati

8

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Asim Kumar Debnath

9

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

number of pages

13

1 reference

based on heuristic

inferred from page(s)

language of work

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

339

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

213-225

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

Virus attachment and entry offer numerous targets for antiviral therapy

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

HIV-1 integrase: a target for new AIDS chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Structure of an unliganded simian immunodeficiency virus gp120 core

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

HIV-1 cell entry and advances in viral entry inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Novel compounds in preclinical/early clinical development for the treatment of HIV infections

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120?CD4 complex in transgenic mice that produce human immunoglobulins

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Peptide and non-peptide HIV fusion inhibitors

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Optimizing the hit-to-lead process using SPR analysis

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

New brominated and halogen-less derivatives and structure-activity relationship of azaphilones inhibiting gp120-CD4 binding.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Coreceptors--Implications for HIV Pathogenesis and Therapy

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

HIV co-receptors as targets for antiviral therapy

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Interaction of an anti-HIV peptide, T22, with gp120 and CD4.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

A novel assay to identify entry inhibitors that block binding of HIV-1 gp120 to CCR5.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and inhibitory activities of isochromophilone analogues against gp120-CD4 binding

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.06.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.06.008

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/15996703

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53851964&oldid=1772537252"